Recent publications published by researchers at the MRC WIMM.
Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS.
Feldman ER. et al, (2025), Genet Epidemiol, 49
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study
Hughes SE. et al, (2025), Eclinicalmedicine, 84
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisions
AHMED A., (2025), Clinical Cancer Research
Immune perturbation by the ileal microbiota in multiple sclerosis.
Jensen LT. and Fugger L., (2025), Proc Natl Acad Sci U S A, 122
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse.
Van Der Maas NG. et al, (2025), Blood Adv
Clonal tracing with somatic epimutations reveals dynamics of blood ageing.
Scherer M. et al, (2025), Nature
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.
Sirenko M. et al, (2025), Cell Stem Cell
Protocol for high-quality RNA sequencing, cell surface protein analysis, and genotyping in single cells using TARGET-seq.
Jakobsen NA. et al, (2025), STAR Protoc, 6
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.
Chen J-L. et al, (2025), Nat Commun, 16
Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease.
FitzPatrick MEB. et al, (2025), Nat Immunol
LCN2-mediated ferroptosis resistance in tissue homeostasis and early-stage tumorigenesis of the fallopian tube epithelium
Imaeda K. et al, (2025), iScience, 112654 - 112654
Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond
Teoh PJ. et al, (2025), Haematologica, 110, 1074 - 1091
The Structural Biology of T-Cell Antigen Detection at Close Contacts.
Lui Y. et al, (2025), Immunol Rev, 331
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Milotay G. et al, (2025), Nature Medicine